Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors

Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group Design and synthesis of phthalimide-type histone deacetylase inhibitors Indole amide hydroxamic acids as potent inhibitors of histone deacetylases Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity Design and synthesis of a novel class of histone deacetylase inhibitors Novel N-hydroxybenzamide-based HDAC inhibitors with branched CAP group Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents